Session information

Morning Seminar

MS2-8

3rd generation TKI treatment for Ph+ALL

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Isamu Sugiura (Division of Hematology and Oncology, Toyohashi Municipal Hospital)

Sponsor: Otsuka Pharmaceuticals Co., Ltd

[MS2-8] 3rd generation TKI treatment for Ph+ALL

Kenjiro Mitsuhashi¹, Junichi Sugita² (1.Department of Hematology, Saitama Red Cross Hospital, 2.Department of Hematology, Hokkaido University Hospital)

▲